Literature DB >> 3024464

Inciting excitotoxic cytocide among central neurons.

J W Olney.   

Abstract

Here I have reviewed evidence from electron microscopic studies showing that each of several sustained limbic seizure syndromes is associated with a type of acute brain damage which is ultrastructurally indistinguishable from the brain damage induced by Glu and other excitotoxins. In addition, I have presented evidence that persistent stimulation of specific axonal tracts that use Glu as transmitter results in Glu-like excitotoxic degeneration of postsynaptic neurons innervated by such tracts. Phencyclidine and ketamine, which powerfully block the neurotoxicity of the Glu analog NMA, protect against seizure-related brain damage. This may be explained by either an anticonvulsant or antiexcitotoxic mechanism, or both. Recent evidence suggests that an excitotoxic mechanism (excessive activation of Glu/Asp receptors) may underlie both seizure-mediated and anoxic brain damage. The acute fulminating type of neuronal degeneration induced by Glu is a Na+ and Cl- but not Ca2+ dependent phenomenon. According to a recent study, however, Glu may induce neuronal necrosis not only by an acute Ca2+ independent process but by a more slowly evolving Ca2+ dependent process. If, as these data suggest, an excitotoxic mechanism underlies brain damage associated with anoxia and epilepsy, a better understanding of excitotoxic mechanisms may lead eventually to prophylactic approaches for preventing such forms of brain damage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024464     DOI: 10.1007/978-1-4684-7971-3_48

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  36 in total

1.  Decreased G-protein-mediated regulation and shift in calcium channel types with age in hippocampal cultures.

Authors:  E M Blalock; N M Porter; P W Landfield
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens.

Authors:  L L Zaulyanov; P S Green; J W Simpkins
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

3.  Oxidative glutamate toxicity can be a component of the excitotoxicity cascade.

Authors:  D Schubert; D Piasecki
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

4.  Electrophysiological mechanisms of delayed excitotoxicity: positive feedback loop between NMDA receptor current and depolarization-mediated glutamate release.

Authors:  C M Norris; E M Blalock; O Thibault; L D Brewer; G V Clodfelter; N M Porter; P W Landfield
Journal:  J Neurophysiol       Date:  2006-08-16       Impact factor: 2.714

5.  Neuroprotection of atractylenolide III from Atractylodis macrocephalae against glutamate-induced neuronal apoptosis via inhibiting caspase signaling pathway.

Authors:  Chao Liu; Hong Zhao; Zhi-Hong Ji; Xin-Yu Yu
Journal:  Neurochem Res       Date:  2014-06-24       Impact factor: 3.996

Review 6.  The pilocarpine model of epilepsy.

Authors:  E A Cavalheiro
Journal:  Ital J Neurol Sci       Date:  1995 Feb-Mar

7.  A sensory brain map for each behavior?

Authors:  W Metzner; J Juranek
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line.

Authors:  D P Younkin; C M Tang; M Hardy; U R Reddy; Q Y Shi; S J Pleasure; V M Lee; D Pleasure
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

Review 9.  Pathogenesis of diencephalic lesions in an experimental model of Wernicke's encephalopathy.

Authors:  P J Langlais
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

10.  [Glutamate neurotoxicity during spinal cord ischemia--neuroprotective effects of glutamate receptor antagonists].

Authors:  T Nakamichi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.